1.
Dattola A, Bernardini N, Campione E, Amore E, Amato S, Caldarola G, et al. Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy. Dermatol Pract Concept [Internet]. 2025 Apr. 11 [cited 2026 Feb. 3];15(2):4976 . Available from: https://dpcj.org/index.php/dpc/article/view/4976